Digital-enabled opioid use disorder treatment provider Ophelia Health raised $50 million in a Series B funding round, Behavioral Health Business reports.
The New York City-based company announced that Tiger Global Management led the round, which also saw participation from Good Friends, Menlo Ventures, General Catalyst, Refactor Capital, 640 Oxford Ventures, Interplay Ventures and PillPack founder Elliot Cohen. Read more.
